An mRNA booster for cellular immunotherapy shows potential against aggressive brain tumors
A team led by researchers at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) has developed a new approach to more effectively direct immune cells against glioblastomas. In experimental models, they were able to show that a targeted mRNA vaccine significantly increases the potency of therapeutic immune cells. The paper is published in the journal Cancer…
Read original article on Medical Xpress - latest medical and health news stories →